Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JNJ compared with ABT: revenue, margins and what each company keeps, and the suppliers and customers both name
JNJ
Johnson & Johnson
Change
Mkt cap
Revenue
Revenue
ABT
Abbott Laboratories
Change
Mkt cap
Revenue
Revenue
vs
Compare
JNJ
Johnson & Johnson
vs
ABT
Abbott Laboratories
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
JNJ
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.1%
▼
−5.73%
×1.84
Q2 FY26
±2.9%
▼
−2.69%
×0.93
Q1 FY26
±3.0%
▲
+0.90%
×0.30
Jan 21 '26
±2.8%
▼
−0.09%
×0.04
ABT
3 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 21 '26
±5.3%
▼
−1.89%
×0.36
Q2 FY26
±4.3%
▲
+10.71%
×2.49
= implied
JNJ realized, solid
ABT realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.4%
▼
−6.00%
×1.36
Jan 22 '26
±3.2%
▼
−10.04%
×3.13
JNJ
Johnson & Johnson
Change
273.66
· pre 272.99
Mkt cap
$657.7B
Revenue
$25.4B
Q3 FY26
Revenue
$94.2B
FY25
ABT
Abbott Laboratories
Change
106.21
· pre 105.58
Pre-market
Sep 2 '83
Mkt cap
$183.8B
Revenue
$12.6B
Q2 FY26
Revenue
$44.3B
FY25
vs
Compare
Pre-market
Sep 2 '83
JNJ
Johnson & Johnson
vs
ABT
Abbott Laboratories
273.66
pre 272.99
Price
106.21
pre 105.58
$657.7B
Mkt cap
$183.8B
Q3 FY26
$25.4B
Revenue
$12.6B
Q2 FY26
FY25
$94.2B
Revenue
$44.3B
FY25
Change
Change
JNJ
273.66
vs
ABT
106.21
Pre-market
Sep 2 '83